Efg Asset Management (North America) Corp. Vera Therapeutics, Inc. Transaction History
Efg Asset Management (North America) Corp.
- $705 Million
- Q4 2024
A detailed history of Efg Asset Management (North America) Corp. transactions in Vera Therapeutics, Inc. stock. As of the latest transaction made, Efg Asset Management (North America) Corp. holds 73,160 shares of VERA stock, worth $2.03 Million. This represents 0.44% of its overall portfolio holdings.
Number of Shares
73,160
Previous 45,968
59.15%
Holding current value
$2.03 Million
Previous $2.03 Million
52.29%
% of portfolio
0.44%
Previous 0.35%
Shares
4 transactions
Others Institutions Holding VERA
# of Institutions
193Shares Held
63.9MCall Options Held
68.1KPut Options Held
88.6K-
Avoro Capital Advisors LLC New York, NY5.61MShares$155 Million3.46% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD4.38MShares$121 Million0.02% of portfolio
-
Black Rock Inc. New York, NY3.34MShares$92.5 Million0.0% of portfolio
-
Abingworth LLP London, X02.96MShares$82 Million19.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.95MShares$81.7 Million0.0% of portfolio
About Vera Therapeutics, Inc.
- Ticker VERA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 27,042,300
- Market Cap $749M
- Description
- Vera Therapeutics, Inc., a clinical stage biotechnology company, focuses on developing and commercializing treatments for patients with serious immunological diseases in the United States. Its lead product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection that is in Phase IIb clinical trial for patients with ...